Voya Investment Management LLC Pmv Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.51 - $3.12 $4,321 - $8,929	-2,862 Reduced 16.95%	14,020 $23,000
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $8,498 - $13,524	2,157 Added 14.65%	16,882 $105,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $11,217 - $16,905	984 Added 7.16%	14,725 $175,000
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $31,677 - $76,979	3,432 Added 33.29%	13,741 $196,000
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $619 - $937	31 Added 0.3%	10,309 $238,000
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $111,563 - $143,427	3,983 Added 63.27%	10,278 $351,000
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $40,777 - $65,835	1,330 Added 26.79%	6,295 $207,000
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $158,184 - $305,397	4,965 New	4,965 $305,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.